Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Jul;58(1):88–90. doi: 10.1038/bjc.1988.169

Prognostic value of continuous variables in breast cancer and head and neck cancer. Dependence on the cut-off level.

A Courdi 1, M Héry 1, P Chauvel 1, J Gioanni 1, M Namer 1, F Demard 1
PMCID: PMC2246491  PMID: 3166897

Full text

PDF
88

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes D. M., Ribeiro G. G., Skinner L. G. Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment. Eur J Cancer. 1977 Oct;13(10):1133–1143. doi: 10.1016/0014-2964(77)90012-3. [DOI] [PubMed] [Google Scholar]
  2. Borjesson B. W., McGinley R., Foo T. M., Smyth C., Toppila M., Compton P., Sarfaty G. A. Estrogen and progesterone receptor assays in human breast cancer: sources of variation between laboratories. Eur J Cancer Clin Oncol. 1987 Jul;23(7):999–1004. doi: 10.1016/0277-5379(87)90349-x. [DOI] [PubMed] [Google Scholar]
  3. Clark G. M., McGuire W. L. Progesterone receptors and human breast cancer. Breast Cancer Res Treat. 1983;3(2):157–163. doi: 10.1007/BF01803558. [DOI] [PubMed] [Google Scholar]
  4. Courdi A., Tubiana M., Chavaudra N., Malaise E. P., Le Fur R. Changes in labeling indices of human tumors after irradiation. Int J Radiat Oncol Biol Phys. 1980 Dec;6(12):1639–1644. doi: 10.1016/0360-3016(80)90245-x. [DOI] [PubMed] [Google Scholar]
  5. Dressler L. G., Seamer L. C., Owens M. A., Clark G. M., McGuire W. L. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer. 1988 Feb 1;61(3):420–427. doi: 10.1002/1097-0142(19880201)61:3<420::aid-cncr2820610303>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  6. Forrest A. P., Black R. B., Humeniuk V., Cant E. L., Hawkins R. A., Prescott R. J., Roberts M. M., Shivas A. A., Stewart H. J., Smith A. F. Preoperative assessment and staging of breast cancer: preliminary communication. J R Soc Med. 1980 Aug;73(8):561–566. doi: 10.1177/014107688007300805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gentili C., Sanfilippo O., Silvestrini R. Cell proliferation and its relationship to clinical features and relapse in breast cancers. Cancer. 1981 Aug 15;48(4):974–979. doi: 10.1002/1097-0142(19810815)48:4<974::aid-cncr2820480420>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  8. Gioanni J., Farges M. F., Lalanne C. M., Francoual M., Namer M. Thymidine labeling index and estrogen receptor level in 64 human breast cancers. Biomedicine. 1979 Dec;31(8):239–243. [PubMed] [Google Scholar]
  9. Hartveit F., Thorsen T., Tangen M., Maehle B. O., Thoresen S., Halvorsen J. F. Sinophobic growth in oestrogen receptor-negative metastatic breast cancer. Oncology. 1983;40(4):241–243. doi: 10.1159/000225735. [DOI] [PubMed] [Google Scholar]
  10. Howat J. M., Harris M., Swindell R., Barnes D. M. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br J Cancer. 1985 Feb;51(2):263–270. doi: 10.1038/bjc.1985.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Héry M., Gioanni J., Lalanne C. M., Namer M., Courdi A. The DNA labelling index: a prognostic factor in node-negative breast cancer. Breast Cancer Res Treat. 1987;9(3):207–211. doi: 10.1007/BF01806381. [DOI] [PubMed] [Google Scholar]
  12. Jensen E. V., Block G. E., Smith S., Kyser K., DeSombre E. R. Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monogr. 1971 Dec;34:55–70. [PubMed] [Google Scholar]
  13. Jordan V. C., Zava D. T., Eppenburger U., Kiser A., Sebek S., Dowdle E., Krozowski Z., Bennett R. C., Funder J., Holdaway I. M. Reliability of steroid hormone receptor assays: an international study. Eur J Cancer Clin Oncol. 1983 Mar;19(3):357–363. doi: 10.1016/0277-5379(83)90133-5. [DOI] [PubMed] [Google Scholar]
  14. Mason B. H., Holdaway I. M., Mullins P. R., Yee L. H., Kay R. G. Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res. 1983 Jun;43(6):2985–2990. [PubMed] [Google Scholar]
  15. Meyer J. S., McDivitt R. W., Stone K. R., Prey M. U., Bauer W. C. Practical breast carcinoma cell kinetics: review and update. Breast Cancer Res Treat. 1984;4(2):79–88. doi: 10.1007/BF01806389. [DOI] [PubMed] [Google Scholar]
  16. Meyer J. S., Stevens S. C., White W. L., Hixon B. Estrogen receptor assay of carcinomas of the breast by a simplified dextran--charcoal method. Am J Clin Pathol. 1978 Oct;70(4):655–664. doi: 10.1093/ajcp/70.4.655. [DOI] [PubMed] [Google Scholar]
  17. Müller R. P., Addicks H. W., Meier E. M. Pretherapeutic flow cytometric DNA investigations in radiotherapy patients with maxillo-facial carcinomas. Int J Radiat Oncol Biol Phys. 1985 Sep;11(9):1613–1619. doi: 10.1016/0360-3016(85)90213-5. [DOI] [PubMed] [Google Scholar]
  18. Silvestrini R., Daidone M. G., Di Fronzo G., Morabito A., Valagussa P., Bonadonna G. Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer. Breast Cancer Res Treat. 1986;7(3):161–169. doi: 10.1007/BF01806246. [DOI] [PubMed] [Google Scholar]
  19. Silvestrini R., Molinari R., Costa A., Volterrani F., Gardani G. Short-term variation in labeling index as a predictor of radiotherapy response in human oral cavity carcinoma. Int J Radiat Oncol Biol Phys. 1984 Jul;10(7):965–970. doi: 10.1016/0360-3016(84)90164-0. [DOI] [PubMed] [Google Scholar]
  20. Stewart J. F., King R. J., Winter P. J., Tong D., Hayward J. L., Rubens R. D. Oestrogen receptors, clinical features and prognosis in stage III breast cancer. Eur J Cancer Clin Oncol. 1982 Dec;18(12):1315–1320. doi: 10.1016/0277-5379(82)90135-3. [DOI] [PubMed] [Google Scholar]
  21. Sutton R., Campbell M., Cooke T., Nicholson R., Griffiths K., Taylor I. Predictive power of progesterone receptor status in early breast carcinoma. Br J Surg. 1987 Mar;74(3):223–226. doi: 10.1002/bjs.1800740325. [DOI] [PubMed] [Google Scholar]
  22. Tubiana M., Pejovic M. H., Chavaudra N., Contesso G., Malaise E. P. The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer. 1984 Apr 15;33(4):441–445. doi: 10.1002/ijc.2910330404. [DOI] [PubMed] [Google Scholar]
  23. Vollenweider-Zerargui L., Barrelet L., Wong Y., Lemarchand-Béraud T., Gómez F. The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients. Cancer. 1986 Mar 15;57(6):1171–1180. doi: 10.1002/1097-0142(19860315)57:6<1171::aid-cncr2820570618>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  24. Volm M., Mattern J., Sonka J., Vogt-Schaden M., Wayss K. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry. 1985 Jul;6(4):348–356. doi: 10.1002/cyto.990060412. [DOI] [PubMed] [Google Scholar]
  25. Wrange O., Nordenskjöld B., Gustafsson J. A. Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel. Anal Biochem. 1978 Apr;85(2):461–475. doi: 10.1016/0003-2697(78)90243-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES